Literature DB >> 23019348

Update in TSH receptor agonists and antagonists.

Marvin C Gershengorn1, Susanne Neumann.   

Abstract

The physiological role of the TSH receptor (TSHR) as a major regulator of thyroid function is well understood, but TSHRs are also expressed in multiple normal extrathyroidal tissues, and the physiological roles of TSHRs in these tissues are unclear. Moreover, TSHRs play a major role in several pathological conditions including hyperthyroidism, hypothyroidism, and thyroid tumors. Small molecule, "drug-like" TSHR agonists, neutral antagonists, and inverse agonists may be useful as probes of TSHR function in extrathyroidal tissues and as leads to develop drugs for several diseases of the thyroid. In this Update, we review the most recent findings regarding the development and use of these small molecule TSHR ligands.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019348      PMCID: PMC3513532          DOI: 10.1210/jc.2012-3080

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  TSH Receptor Mutations and Thyroid Disease.

Authors:  L Duprez; J Parma; J Van Sande; P Rodien; J E Dumont; G Vassart; M Abramowicz
Journal:  Trends Endocrinol Metab       Date:  1998 May-Jun       Impact factor: 12.015

Review 2.  Graves' ophthalmopathy.

Authors:  Rebecca S Bahn
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

3.  TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.

Authors:  Jane Sanders; Ricardo Núñez Miguel; Jadwiga Furmaniak; Bernard Rees Smith
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

4.  Evaluation of small-molecule modulators of the luteinizing hormone/choriogonadotropin and thyroid stimulating hormone receptors: structure-activity relationships and selective binding patterns.

Authors:  Susanna Moore; Holger Jaeschke; Gunnar Kleinau; Susanne Neumann; Stefano Costanzi; Jian-kang Jiang; John Childress; Bruce M Raaka; Anny Colson; Ralf Paschke; Gerd Krause; Craig J Thomas; Marvin C Gershengorn
Journal:  J Med Chem       Date:  2006-06-29       Impact factor: 7.446

5.  Thyrotropin receptor stimulates internalization-independent persistent phosphoinositide signaling.

Authors:  Alisa Boutin; Michael D Allen; Elizabeth Geras-Raaka; Wenwei Huang; Susanne Neumann; Marvin C Gershengorn
Journal:  Mol Pharmacol       Date:  2011-04-27       Impact factor: 4.436

6.  A low-molecular-weight antagonist for the human thyrotropin receptor with therapeutic potential for hyperthyroidism.

Authors:  Susanne Neumann; Gunnar Kleinau; Stefano Costanzi; Susanna Moore; Jian-kang Jiang; Bruce M Raaka; Craig J Thomas; Gerd Krause; Marvin C Gershengorn
Journal:  Endocrinology       Date:  2008-07-31       Impact factor: 4.736

Review 7.  Resistance to thyrotropin.

Authors:  S Refetoff
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

8.  A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR).

Authors:  Holger Jäschke; Susanne Neumann; Susanna Moore; Craig J Thomas; Anny-Odile Colson; Stefano Costanzi; Gunnar Kleinau; Jian-Kang Jiang; Ralf Paschke; Bruce M Raaka; Gerd Krause; Marvin C Gershengorn
Journal:  J Biol Chem       Date:  2006-02-16       Impact factor: 5.157

9.  Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter.

Authors:  Søren Fast; Viveque Egsgaard Nielsen; Peter Grupe; Henrik Boel-Jørgensen; Lars Bastholt; Peter Bøgeskov Andersen; Steen Joop Bonnema; Laszlo Hegedüs
Journal:  J Clin Endocrinol Metab       Date:  2012-05-10       Impact factor: 5.958

10.  A lack of thyroid hormones rather than excess thyrotropin causes abnormal skeletal development in hypothyroidism.

Authors:  J H Duncan Bassett; Allan J Williams; Elaine Murphy; Alan Boyde; Peter G T Howell; Rowan Swinhoe; Marta Archanco; Frédéric Flamant; Jacques Samarut; Sabine Costagliola; Gilbert Vassart; Roy E Weiss; Samuel Refetoff; Graham R Williams
Journal:  Mol Endocrinol       Date:  2007-10-11
View more
  23 in total

Review 1.  The cell biology of the thyroid-disrupting mechanism of dichlorodiphenyltrichloroethane (DDT).

Authors:  M Rossi; A R Taddei; I Fasciani; R Maggio; F Giorgi
Journal:  J Endocrinol Invest       Date:  2017-06-21       Impact factor: 4.256

2.  Inhibiting thyrotropin/insulin-like growth factor 1 receptor crosstalk to treat Graves' ophthalmopathy: studies in orbital fibroblasts in vitro.

Authors:  Robert F Place; Christine C Krieger; Susanne Neumann; Marvin C Gershengorn
Journal:  Br J Pharmacol       Date:  2017-01-27       Impact factor: 8.739

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  New small molecule agonists to the thyrotropin receptor.

Authors:  Rauf Latif; M Rejwan Ali; Risheng Ma; Martine David; Syed A Morshed; Michael Ohlmeyer; Dan P Felsenfeld; Zerlina Lau; Mihaly Mezei; Terry F Davies
Journal:  Thyroid       Date:  2015-01       Impact factor: 6.568

5.  Modulating TSH Receptor Signaling for Therapeutic Benefit.

Authors:  Gerd Krause; Anja Eckstein; Ralf Schülein
Journal:  Eur Thyroid J       Date:  2020-11-23

Review 6.  Thyroid eye disease: current and potential medical management.

Authors:  Jessica M Pouso-Diz; Jose M Abalo-Lojo; Francisco Gonzalez
Journal:  Int Ophthalmol       Date:  2020-01-09       Impact factor: 2.031

7.  A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathy.

Authors:  Adina F Turcu; Seema Kumar; Susanne Neumann; Michael Coenen; Seethalakshmi Iyer; Pamela Chiriboga; Marvin C Gershengorn; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2013-03-12       Impact factor: 5.958

8.  A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice.

Authors:  Susanne Neumann; Eshel A Nir; Elena Eliseeva; Wenwei Huang; Juan Marugan; Jingbo Xiao; Andrés E Dulcey; Marvin C Gershengorn
Journal:  Endocrinology       Date:  2013-12-04       Impact factor: 4.736

Review 9.  Novel insights on thyroid-stimulating hormone receptor signal transduction.

Authors:  Gunnar Kleinau; Susanne Neumann; Annette Grüters; Heiko Krude; Heike Biebermann
Journal:  Endocr Rev       Date:  2013-05-03       Impact factor: 19.871

10.  2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.

Authors:  George J Kahaly; Luigi Bartalena; Lazlo Hegedüs; Laurence Leenhardt; Kris Poppe; Simon H Pearce
Journal:  Eur Thyroid J       Date:  2018-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.